Long read sequencing is crucial for detecting novel genomic elements due to its ability to capture intricate features often overlooked by short reads. Its capacity to span large insertions, intricate rearrangements, and non-coding regions enhances the identification of previously elusive genes, regulatory elements, and functional components within the genome. It provides a more comprehensive and detailed view of the genetic landscape. Long read sequencing significantly advances human understanding of genomic complexity and facilitates the discovery of essential elements that play critical roles in various biological processes.
According to Data Bridge Market Research analyses, the Global Long Read Sequencing Market was USD 519.64 million in 2022 and is expected to reach USD 2,533.57 million by 2030 and is expected to undergo a CAGR of 21.9% during the forecast period 2023-2030.
"Rise in incidences of genetic disorders boosts the market growth"
The surge in incidences of genetic disorders has emerged as a significant driver for the global long read sequencing market. The increasing prevalence of genetic disorders necessitates advanced genomic technologies for accurate and comprehensive DNA analysis, driving the demand for long read sequencing methods. Long read sequencing enables the thorough examination of complex genomic structures, facilitating precise identification and understanding of genetic abnormalities. This technology plays a crucial role in unraveling the intricate genetic basis of disorders, aiding in early detection, personalized medicine, and targeted therapeutic interventions.
What restraints the growth of the global long read sequencing market?
“High costs associated with the market hinder its growth”
The higher cost per base relative to short-read sequencing is a significant constraint in the global long read sequencing market. The cost disparity impedes widespread adoption, limiting the market's growth as it poses financial challenges for research and diagnostic applications. The economic barrier associated with long-read sequencing may deter potential users and hinder the technology's accessibility, thus restraining its broader market penetration.
Segmentation: Global Long Read Sequencing Market
The global long read sequencing market is segmented on the basis of technology, product, workflow, and end-user.
- On the basis of technology, the global long read sequencing market is segmented into single-molecule real- time sequencing, nanopore sequencing, synthetic long read sequencing, and others
- On the basis of product, the global long read sequencing market is segmented into instruments, consumables, and services
- On the basis of application, the global long read sequencing market is segmented into whole genome sequencing, epigenetics, RNA sequencing, complex population, targeted sequencing, and others
- On the basis of workflow, the global long read sequencing market is segmented into pre-sequencing, sequencing, and data analysis
- On the basis of end-user, the global long read sequencing market is segmented into academic and research institutes, clinical laboratories, hospitals, pharma and biotech entities, and others
Regional Insights: North America dominates the Global Long Read Sequencing Market
North America dominates the global long read sequencing market from 2023 to 2030, driven by many companies, robust research and development capabilities, and continuous advancements. The region's dominance is attributed to a high concentration of industry players and a proactive approach to shaping the trajectory of the long-read sequencing market.
The Asia-Pacific region is expected to experience rapid growth between 2023 and 2030, driven by the expansion of key industry players into emerging Asian markets. This surge is further propelled by the growing emphasis on forward-thinking diagnostics projects, contributing to the region's cumulative strength in the field.
To know more about the study, visit https://www.databridgemarketresearch.com/reports/global-long-read-sequencing-market
Recent Developments in the Global Long Read Sequencing Market
- In March 2019, Oxford Nanopore introduced Flongle, revolutionizing rapid analysis of short DNA/RNA sequences. This adaptable tool complements GridION X5 desktop and MinION portable sequencing, featuring compact Flange cells capable of generating up to 1.8 Gb of sequence data, with potential expansion to over 3 Gb. This strategic product enhancement aims to bolster the company's diverse portfolio, reinforcing its position in the genomics market
The Prominent Key Players Operating in the Global Long Read Sequencing Market Include:
- Illumina, Inc. (U.S.)
- MicrobesNG (U.S.)
- Roche Sequencing (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- PacBio (U.S.)
- Oxford Nanopore Technologies plc (U.K.)
- Quantapore, Inc. (U.S.)
- FG Technologies (Switzerland)
- BaseClear B.V (Netherlands)
- INSTITUTE OF INTEGRATIVE CELL BIOLOGY AND PHYSIOLOGY (France)
- The Garvan Institute (Australia)
- France Génomique (France)
- Takara Holdings Inc. (Japan)
- Genexa AG (Switzerland)
Above are the key players covered in the report, to know about more and exhaustive list of global long read sequencing market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Long Read Sequencing Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
